Skip to main content
Clinical Trials/IRCT20230606058397N1
IRCT20230606058397N1
Recruiting
Phase 1

Investigating the effectiveness of mirtazapine in reducing dependence and the temptation to consume amphetamine and methamphetamine patients referred to addiction treatment clinics

Ahvaz University of Medical Sciences0 sites84 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
84
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • At least one positive urine test for methamphetamine during the hospitalization period
  • Absence of current acute illness
  • Absence of serious chronic diseases
  • Able and willing to provide informed consent and adhere to the visit schedule

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials